Highlights IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
499.3 ^USD	+2.06%		+4.82%	-10.04%

Apr. 01	Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	MT
Apr. 01	Elanco appoints two directors after settling with activist Ancora	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ancora seeks four board seats at Elanco amid push for changes	Feb. 29	RE
Ancora seeks four board seats at Elanco amid push for changes, sources say	Feb. 29	RE
Idexx Launches Vellotm, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect	Feb. 15	CI
Pet products maker Zoetis sees annual profit below estimates on weak demand	Feb. 13	RE
IDEXX Laboratories Shares Rise After Q4 Beat	Feb. 05	MT
IDEXX Laboratories Seeks Acquisitions	Feb. 05	CI
IDEXX Laboratories sees 2024 revenue above estimates	Feb. 05	RE
IDEXX Laboratories' Q4 Earnings, Revenue Increase	Feb. 05	MT
Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q4 Revenue $901.6M, vs. Street Est of $890.6M	Feb. 05	MT
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	Feb. 05	CI
IDEXX Laboratories, Inc. Provides Financial Guidance for 2024	Feb. 05	CI
IDEXX Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 05	CI
IDEXX Laboratories, Inc. Expands Snap Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-Borne Diseases	Nov. 08	CI
Zoetis cuts annual sales forecast as inflation weights on pet spending	Nov. 02	RE
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	Nov. 01	CI
IDEXX Laboratories Q3 Comparable Earnings, Revenue Rise; 2023 Revenue Outlook Cut	Nov. 01	MT
Earnings Flash (IDXX) IDEXX LABORATORIES Reports Q3 Revenue $915.5M, vs. Street Est of $927.3M	Nov. 01	MT
IDEXX Laboratories, Inc. Provides Financial Guidance for 2023	Nov. 01	CI
IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	23-08-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Idexx Laboratories: Superior growth prospects

March 11, 2024 at 01:18 pm EDT